Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography

Eye

Volumn 24, Issue 10, 2010, Pages 1545-1553

  Ophir, A ^a,b   Martinez, M R ^a   Mosqueda, P ^a   Trevino, A ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

epiretinal membrane; Extrafoveal vitreous traction; macular edema; optical coherence tomography; vitreofoveal traction; vitreoschisis

Indexed keywords

ADULT; AGED; ARTICLE; CAPILLARY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; EPIRETINAL MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROANEURYSM; OPTICAL COHERENCE TOMOGRAPHY; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; VITREOUS BODY;

EID: 78049480347     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.80     Document Type: Article

References (36)

1. Early Treatment Diabetic Retinopathy Study Research Group R. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS No. 19. Arch Ophthalmol 1995;113:1144-1155.
2. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema: long term visual results. Ophthalmology 1991;98:1594-1602.
3. Gandorfer A. Diffuse diabetic macular edema: pathology and implications for surgery. Dev Ophthalmol 2007;39:88-95.
4. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
5. Shinura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 2008;145:854-861.
6. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
7. Thomas D, Bunce C, Moorman C, Laidlaw AH. Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation and subretinal fluid in patients with diabetic macular edema. Retina 2005;25:883-888.
8. Ophir A, Trevino A, Fatum S. Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 2010;24:347-353.
9. Ghazi NG, Ciralsky JB, Shah SM, Campochiaro PA, Haller JA. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol 2007;144:747-754.
10. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003;135:169-177.
11. Song SJ, Sohn JH, Park KH. Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome. Korean J Ophthalmol 2007;21:146-150.
12. Karatas M, Ramirez JA, Ophir A. Diabetic vitreopapillary traction and macular oedema. Eye 2005;19:676-682.
13. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001;132:369-377.
14. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 2005;139:638-652.
15. Sakimoto S, Saito Y, Nakata K, Sakamoto Y, Tatebayashi M. Surgical outcomes of epiretinal membrane removal after successful pars plana vitrectomy for retinal diseases. Jpn J Ophthalmol 2008;52:227-230.
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
17. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
18. Nagpala PG, Malik AB, Vuong PT, Lum H. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 1996;166:249-255.
19. Oku H, Kida T, Sugiyama T, Hamada J, Sato B, Ikeda T. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina 2001;21:647-651.
20. Hernández C, Fonollosa A, García-Ramírez M, Higuera M, Catalán R, Miralles A et al. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006;29:2028-2033.
21. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009;54:1-32.
22. Park JH, Woo SJ, Ha YJ, Yu HG. Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2009;247:1009-1017.
23. Falker-Radler CI, Glittenberg C, Binder S. Spectral domain high-definition optical coherence tomography in patients undergoing epiretinal membrane surgery. Ophthalmic Surg Lasers Imaging 2009;40:270-276.
24. Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S et al. Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 2007;114:763-773.
25. Catier A, Tadayoni R, Paques M, Erginay A, Haouchine B, Gaudric A et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 2005;140:200-206.
26. Yamamoto S, Yamamoto T, Hayashi M, Takeuchi S. Morphological and functional analyses of diabetic macular oedema by optical coherence tomography and multifocal electroretinograms. Graefes Arch Clin Exp Ophthalmol 2001;239:96-101.
27. Wilkins JR, Puliafito CA, Hee MR, Duker JS, Reichel E, Coker JG et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology 1996;103:2142-2151.
28. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik Jr JM, Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 2008;145:509-517.
29. Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2004;242:630-637.
30. Figueroa MS, Contreras I, Noval S. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 2008;28:420-426.
31. Patel JI, Hykin PG, Schadt M, Luong V, Bunce C, Fitzke F et al. Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs. macular argon photocoagulation. Eye 2006;20:873-881.
32. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic macular edema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 2001;239:264-270.
33. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006;142:961-969.
34. Appiah AP, Hirose T, Kado M. A review of 324 cases of idiopathic premacular gliosis. Am J Ophthalmol 1988;106:533-535.
35. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997;81:919-926.
36. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-1959.